Specifically, we analyzed EIF4EBP1 mRNA expression levels in EGFR-amplified and EGFR-non-amplified as well as in O6-methylguanine DNA methyltransferase (MGMT) promoter-methylated and promoter-unmethylated IDH-wildtype glioblastoma patient samples using publically available datasets [32]. This evidence concerns the gene EGFR and glioblastoma.